Biogaran is growing and expanding its know-how outside its borders

Since 2012, Biogaran has started it’s internationalization with the acquisition of local Brazilian generic company called Pharlab and more recently, in 2017 with the acquisition of a Nigerian player called Swipha.

Our team’s constant efforts support these 2 subsidiaries in improving its quality standard, as well as enlarging its product portfolio and services to better answer to Brazilian and Nigerian patients’ needs.
Thanks to its international experience in emerging market, and to its expertise in quality management, Biogaran is willing to explore and to expand to other markets worldwide by adapting its business model to the specific needs of each country, thus providing patients worldwide a large range of efficient pharmaceutical products of quality.

map 1 Placeholder
map 1
Markers Placeholder
Back to top